Close Menu
Global Hub News
    What's Hot

    AstraZeneca Faces Setback as Trial Failure Impacts Shares

    July 24, 2026

    Teaser for Avatar: Seven Havens Released, Premiere Date Announced

    July 24, 2026

    Ebola Cases in Congo Near 3,000 Following Data Reassessment

    July 24, 2026
    Facebook X (Twitter) Instagram Threads
    Trending
    • AstraZeneca Faces Setback as Trial Failure Impacts Shares
    • Teaser for Avatar: Seven Havens Released, Premiere Date Announced
    • Ebola Cases in Congo Near 3,000 Following Data Reassessment
    • Star Wars: Detours Release Status and Future Prospects in 2026
    • US Measles Cases Hit 2,318, Exceeding 2025 Total Amid Vaccination Decline
    • Romanian Jet Fighter Downs Suspected Russian Drone Near NATO Airspace
    • Nawaz Sharif Criticizes Bilawal at Mirpur Rally Ahead of AJK Elections
    • Karachi Sees Rain as PMD Forecasts More Showers Across Pakistan This Weekend
    Facebook X (Twitter) Instagram
    Global Hub NewsGlobal Hub News
    Subscribe
    Friday, July 24
    • Home
    • World
    • Pakistan
    • Politics
    • Sports
    • Technology
    • Health
    • Entertainment
    • Business
    • Tax Calculator
    Global Hub News
    Home ยป Trump Administration Ends $1.8bn Anti-Weaponisation Fund Amid DOJ Deal
    World

    Trump Administration Ends $1.8bn Anti-Weaponisation Fund Amid DOJ Deal

    Web DeskBy Web DeskJune 3, 2026No Comments1 Min Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The Trump administration has decided to discontinue the $1.8 billion fund aimed at preventing the misuse of government resources for political purposes. This fund was initially established to address concerns about weaponisation of federal agencies, reflecting ongoing debates about the politicisation of government operations. The move marks a significant shift in the administration’s approach to managing federal oversight and accountability mechanisms.

    Meanwhile, the Department of Justice continues to uphold an agreement with former President Donald Trump that prohibits any future audits into his or his family’s past tax returns. This arrangement has been a point of contention, as it effectively shields the Trump family’s financial records from further scrutiny by tax authorities. The decision underscores the complex legal and political dynamics surrounding transparency and accountability for high-profile political figures.

    In a broader context, ending the anti-weaponisation fund while preserving the audit ban highlights the administration’s priorities in balancing oversight with political considerations. The fund’s termination may impact efforts to curb potential abuses of power within federal agencies, raising questions about future safeguards. At the same time, maintaining the audit agreement reflects ongoing negotiations and legal protections afforded to the former president and his family, influencing public discourse on governance and ethics.

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    Web Desk

    Related Posts

    Romanian Jet Fighter Downs Suspected Russian Drone Near NATO Airspace

    July 24, 2026

    Trump Issues Warning to China and Russia Over Iran Conflict Involvement

    July 24, 2026

    Gaza Residents Struggle to Preserve Food Amid Scorching Heat Without Refrigerators

    July 24, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    AstraZeneca Faces Setback as Trial Failure Impacts Shares

    July 24, 2026

    Teaser for Avatar: Seven Havens Released, Premiere Date Announced

    July 24, 2026

    Ebola Cases in Congo Near 3,000 Following Data Reassessment

    July 24, 2026

    Star Wars: Detours Release Status and Future Prospects in 2026

    July 24, 2026

    US Measles Cases Hit 2,318, Exceeding 2025 Total Amid Vaccination Decline

    July 24, 2026

    Romanian Jet Fighter Downs Suspected Russian Drone Near NATO Airspace

    July 24, 2026
    Don't Miss

    AstraZeneca Faces Setback as Trial Failure Impacts Shares

    By Web DeskJuly 24, 20260

    AstraZeneca encounters a rare challenge following a failed clinical trial, leading to a decline in its stock value amid investor concerns.

    Teaser for Avatar: Seven Havens Released, Premiere Date Announced

    July 24, 2026

    Ebola Cases in Congo Near 3,000 Following Data Reassessment

    July 24, 2026

    Star Wars: Detours Release Status and Future Prospects in 2026

    July 24, 2026
    Facebook X (Twitter) Instagram Pinterest
    • Home
    • Buy Now
    © 2026 NewsOra24

    Type above and press Enter to search. Press Esc to cancel.